GLUE Monte Rosa Therapeutics24.25+8.24 (+51.5%)
After Hours Gainer
GLUE Monte Rosa Therapeutics16.01+1.61+11.2%
After Hours:17.40+1.39 (+8.7%)
Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results
Globe NewswireTue, 6-Jan 4:05 PM
After Hours Gainer
GLUE Monte Rosa Therapeutics16.01+1.61+11.2%
After Hours:17.38+1.37 (+8.6%)
Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results
Globe NewswireTue, 6-Jan 4:05 PM
GLUE Monte Rosa Therapeutics16.01+1.61 (+11.2%)
After Hours:16.35+0.34 (+2.1%)
GLUE Monte Rosa Therapeutics6.58+0.11 (+1.7%)
GLUE Monte Rosa Therapeutics6.51-0.42 (-6.1%)